Abeona Therapeutics Statistics
Total Valuation
ABEO has a market cap or net worth of $284.58 million. The enterprise value is $185.03 million.
Important Dates
The next estimated earnings date is Monday, November 11, 2024, before market open.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ABEO has 43.31 million shares outstanding. The number of shares has increased by 115.29% in one year.
Shares Outstanding | 43.31M |
Shares Change (YoY) | +115.29% |
Shares Change (QoQ) | +87.54% |
Owned by Insiders (%) | 5.14% |
Owned by Institutions (%) | 48.62% |
Float | 28.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | 398.57 |
PB Ratio | 3.74 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.48, with a Debt / Equity ratio of 0.32.
Current Ratio | 7.48 |
Quick Ratio | 7.38 |
Debt / Equity | 0.32 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -25.35 |
Financial Efficiency
Return on equity (ROE) is -127.38% and return on invested capital (ROIC) is -63.48%.
Return on Equity (ROE) | -127.38% |
Return on Assets (ROA) | -37.81% |
Return on Capital (ROIC) | -63.48% |
Revenue Per Employee | n/a |
Profits Per Employee | -$626,179 |
Employee Count | 84 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.09% in the last 52 weeks. The beta is 1.51, so ABEO's price volatility has been higher than the market average.
Beta (5Y) | 1.51 |
52-Week Price Change | +77.09% |
50-Day Moving Average | 5.98 |
200-Day Moving Average | 5.64 |
Relative Strength Index (RSI) | 57.45 |
Average Volume (20 Days) | 223,457 |
Short Selling Information
The latest short interest is 2.77 million, so 6.39% of the outstanding shares have been sold short.
Short Interest | 2.77M |
Short Previous Month | 2.67M |
Short % of Shares Out | 6.39% |
Short % of Float | 9.89% |
Short Ratio (days to cover) | 9.89 |
Income Statement
Revenue | n/a |
Gross Profit | -31.29M |
Operating Income | -56.74M |
Pretax Income | -76.66M |
Net Income | -52.60M |
EBITDA | -54.75M |
EBIT | -56.74M |
Earnings Per Share (EPS) | -$1.78 |
Full Income Statement Balance Sheet
The company has $122.71 million in cash and $23.17 million in debt, giving a net cash position of $99.54 million or $2.30 per share.
Cash & Cash Equivalents | 122.71M |
Total Debt | 23.17M |
Net Cash | 99.54M |
Net Cash Per Share | $2.30 |
Equity (Book Value) | 73.24M |
Book Value Per Share | 1.76 |
Working Capital | 109.06M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$42.20 million and capital expenditures -$1.52 million, giving a free cash flow of -$43.72 million.
Operating Cash Flow | -42.20M |
Capital Expenditures | -1.52M |
Free Cash Flow | -43.72M |
FCF Per Share | -$1.01 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | -1,155.34% |
Dividends & Yields
ABEO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -115.29% |
Shareholder Yield | -115.29% |
Earnings Yield | -18.48% |
FCF Yield | -15.36% |
Dividend Details Analyst Forecast
The average price target for ABEO is $18.00, which is 173.97% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $18.00 |
Price Target Difference | 173.97% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 144.16% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
The last stock split was on July 5, 2022. It was a reverse split with a ratio of 0.04:1.
Last Split Date | Jul 5, 2022 |
Split Type | Reverse |
Split Ratio | 0.04:1 |
Scores
ABEO has an Altman Z-Score of -7.19 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -7.19 |
Piotroski F-Score | 2 |